Supplementation with a highly concentrated docosahexaenoic acid plus xanthophyll carotenoid multivitamin in nonproliferative diabetic retinopathy: prospective controlled study of macular function by fundus microperimetry

References

• CheungNMitchellPWongTYDiabetic retinopathyLancet2010376973512413620580421
   PubMed Web of Science ®Google Scholar
• Executive SummaryIFD Diabetes Atlas8th editionBrussels, BelgiumInternational Diabetes Federation Available from: http://www.diabetesatlas.org/Accessed July 15, 2017
   Google Scholar
• ZhangXZhaoJZhaoTLiuHEffects of intensive glycemic control in ocular complications in patients with type 2 diabetes: a meta-analysis of randomized clinical trialsEndocrine2015491788925355306
   PubMed Web of Science ®Google Scholar
• ChewEYThere is level 1 evidence for intensive glycemic control for reducing the progression of diabetic retinopathy in persons with type 2 diabetesEndocrine20154911325722012
   PubMed Web of Science ®Google Scholar
• DoDVWangXVedulaSSBlood pressure control for diabetic retinopathyCochrane Database Syst Rev20151CD00612725637717
   PubMed Web of Science ®Google Scholar
• OguraSKurataKHattoriYSustained inflammation after pericyte depletion induces irreversible blood-retina barrier breakdownJCI Insight201723e9090528194443
   PubMed Web of Science ®Google Scholar
• RuiaSSaxenaSPrasadSSharmaSRAkdumanLKhannaVKCorrelation of biomarkers thiobarbituric acid reactive substance, nitric oxide and central subfield and cube average thickness in diabetic retinopathy: a cross-sectional studyInt J Retina Vitreous20162827847626
   PubMedGoogle Scholar
• TarrJMKaulKChopraMKohnerEMChibberRPathophysiology of diabetic retinopathyISRN Ophthalmol2013201334356024563789
   PubMedGoogle Scholar
• CaiJBoultonMThe pathogenesis of diabetic retinopathy: old concepts and new questionsEye (Lond)200216324226012032713
   PubMed Web of Science ®Google Scholar
• HernándezCSimó-ServatABogdanovPSimóRDiabetic retinopathy: new therapeutic perspectives based on pathogenic mechanismsJ Endocrinol Invest201740992593528357783
   PubMed Web of Science ®Google Scholar
• SimóRHernándezCEuropean Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR)Neurodegeneration is an early event in diabetic retinopathy: therapeutic implicationsBr J Ophthalmol201296101285129022887976
   PubMed Web of Science ®Google Scholar
• ShindouHKosoHSasakiJDocosahexaenoic acid preserves visual function by maintaining correct disc morphology in retinal photoreceptor cellsJ Biol Chem201729229120541206428578316
   PubMed Web of Science ®Google Scholar
• SanGiovanniJPChewEYThe role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retinaProg Retin Eye Res20052418713815555528
   PubMed Web of Science ®Google Scholar
• ChenWEsselmanWJJumpDBBusikJVAnti-inflammatory effect of docosahexaenoic acid on cytokine-induced adhesion molecule expression in human retinal vascular endothelial cellsInvest Ophthalmol Vis Sci200546114342434716249517
   PubMed Web of Science ®Google Scholar
• RotsteinNPPolitiLEGermanOLGirottiRProtective effect of docosahexaenoic acid on oxidative stress-induced apoptosis of retina photoreceptorsInvest Ophthalmol Vis Sci20034452252225912714668
   PubMed Web of Science ®Google Scholar
• GermanOLInsuaMFGentiliCRotsteinNPPolitiLEDocosahexaenoic acid prevents apoptosis of retina photoreceptors by activating the ERK/MAPK pathwayJ Neurochem20069851507152016923163
   PubMed Web of Science ®Google Scholar
• MukherjeePKMarcheselliVLSerhanCNBazanNGNeuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stressProc Natl Acad Sci U S A2004101228491849615152078
   PubMed Web of Science ®Google Scholar
• DecsiTMindaHHermannRPolyunsaturated fatty acids in plasma and erythrocyte membrane lipids of diabetic childrenProstaglandins Leukot Essent Fatty Acids200267420321012401433
   PubMed Web of Science ®Google Scholar
• CalderPCOmega-3 fatty acids and inflammatory processesNutrients20102335537422254027
   PubMed Web of Science ®Google Scholar
• GalliCCalderPCEffects of fat and fatty acid intake on inflammatory and immune responses: a critical reviewAnn Nutr Metab2009551–312313919752539
   PubMed Web of Science ®Google Scholar
• SzymczakMMurrayMPetrovicNModulation of angiogenesis by omega-3 polyunsaturated fatty acids is mediated by cyclooxygenasesBlood200811173514352118216296
   PubMed Web of Science ®Google Scholar
• MatesanzNParkGMcAllisterHDocosahexaenoic acid improves the nitroso-redox balance and reduces VEGF-mediated angiogenic signaling in microvascular endothelial cellsInvest Ophthalmol Vis Sci201051126815682520702831
   PubMed Web of Science ®Google Scholar
• ThomsonLRToyodaYLangnerAElevated retinal zeaxanthin and prevention of light-induced photoreceptor cell death in quailInvest Ophthalmol Vis Sci200243113538354912407166
   PubMed Web of Science ®Google Scholar
• LiSYFungFKFuZJWongDChanHHLoACAnti-inflammatory effects of lutein in retinal ischemic/hypoxic injury: in vivo and in vitro studiesInvest Ophthalmol Vis Sci201253105976598422871829
   PubMed Web of Science ®Google Scholar
• MaresJLutein and zeaxanthin isomers in eye health and diseaseAnnu Rev Nutr20163657160227431371
   PubMed Web of Science ®Google Scholar
• MadonnaRBalistreriCRGengYJDe CaterinaRDiabetic microangiopathy: pathogenetic insights and novel therapeutic approachesVascul Pharmacol2017901728137665
   PubMed Web of Science ®Google Scholar
• ChucairAJRotsteinNPSangiovanniJPDuringAChewEYPolitiLELutein and zeaxanthin protect photoreceptors from apoptosis induced by oxidative stress: relation with docosahexaenoic acidInvest Ophthalmol Vis Sci200748115168517717962470
   PubMed Web of Science ®Google Scholar
• ConnorKMSanGiovanniJPLofqvistCIncreased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesisNat Med200713786887317589522
   PubMed Web of Science ®Google Scholar
• LafuenteMOrtíLArgenteMThree-year in a randomized single-blind controlled trial of intravitreal ranibizumab and oral supplementation with docosahexaenoic acid and antioxidants for diabetic macular edemaRetina Epub2018222
   Web of Science ®Google Scholar
• BazanNGNeuroprotectin D1 (NPD1): a DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stressBrain Pathol200515215916615912889
   PubMed Web of Science ®Google Scholar
• ZurierRBFatty acids, inflammation and immune responseProstaglandins Leukot Essent Fatty Acids199348157628424124
   PubMed Web of Science ®Google Scholar
• FuZLofqvistCAShaoZDietary ω-3 polyunsaturated fatty acids decrease retinal neovascularization by adipose-endoplasmic reticulum stress reduction to increase adiponectinAm J Clin Nutr2015101487988825833984
   PubMed Web of Science ®Google Scholar
• HuntSIncreased dietary intake of omega-3-PUFA reduces pathological retinal angiogenesisOphthalmologe20071048727729 German17674004
   PubMed Web of Science ®Google Scholar
• OpreanuMLydicTAReidGEMcSorleyKMEsselmanWJBusikJVInhibition of cytokine signaling in human retinal endothelial cells through downregulation of sphingomyelinases by docosahexaenoic acidInvest Ophthalmol Vis Sci20105163253326320071681
   PubMed Web of Science ®Google Scholar
• LafuenteMOrtínLArgenteMCombined intravitreal ranibizumab and oral supplementation with docosahxaenoic acid and antioxidants for diabetic macular edema. Two-year randomized single-blind controlled trial resultsRetina20173771277128627787443
   PubMed Web of Science ®Google Scholar
• SasakiMKawasakiRRogersSThe associations of dietary intake of polyunsaturated fatty acids with diabetic retinopathy in well-controlled diabetesInvest Ophthalmol Vis Sci201556127473747926595607
   PubMed Web of Science ®Google Scholar
• KoehrerPSaabSBerdeauxOErythrocyte phospholipid and polyunsaturated fatty acid composition in diabetic retinopathyPLoS One201499e10691225188352
   PubMed Web of Science ®Google Scholar
• Early Treatment Diabetic Retinopathy Study Research GroupGrading diabetic retinopathy from stereoscopic color fundus photographs – an extension of the modified Airlie House classification: ETDRS report number 10Ophthalmology199198Suppl 57868062062513
   PubMed Web of Science ®Google Scholar
• Results shown in the European Patent EP 1 962 825 B1 (held by BRUDY TECHNOLOGY SL) related to the use of DHA for treating a pathology associated with cellular oxidative damage European patent granted, date April 2, 2014
   Google Scholar
• BogdanovPGassoFDomingoJCDocosahexaenoic acid improves endogenous antioxidant defense in ARPE-19 cellsInvest Ophthalmol Vis Sci2008495932
   Google Scholar
• MangioneCMLeePPGutierrezPRDevelopment of the 25-item National Eye Institute Visual Function Questionnaire (VFQ-25)Arch Ophthalmol20011191050105811448327
   PubMed Web of Science ®Google Scholar
• LepageGRoyCCDirect transesterification of all classes of lipids in a one-step reactionJ Lipid Res19862711141203958609
   PubMed Web of Science ®Google Scholar
• RoismanLRibeiroJCFechineFVDoes microperimetry have a prognostic value in central serous chorioretinopathy?Retina201434471371823975001
   PubMed Web of Science ®Google Scholar
• SinHPLiuDTLamDSLifestyle modification, nutritional and vitamins supplements for age-related macular degenerationActa Ophthalmol201391161122268800
   PubMed Web of Science ®Google Scholar
• EvansJRLawrensonJGAntioxidant vitamin and mineral supplements for slowing the progression of age-related macular degenerationCochrane Database Syst Rev201211CD00025423152201
   PubMed Web of Science ®Google Scholar
• WilliamsMHoggREChakravarthyUAntioxidants and diabetic retinopathyCurr Diab Rep201313448148723649947
   PubMed Web of Science ®Google Scholar
• Rodríguez-CarrizalezADCastellanos-GonzálezJAMartínez-RomeroECOxidants, antioxidants and mitochondrial function in non-proliferative diabetic retinopathyJ Diabetes20146216717523875878
   PubMed Web of Science ®Google Scholar
• GuptaMMChariSLipid peroxidation and antioxidant status in patients with diabetic retinopathyIndian J Physiol Pharmacol200549218719216170987
   PubMedGoogle Scholar
• ArnalEMirandaMJohnsen-SorianoSBeneficial effect of docosahexanoic acid and lutein on retinal structural, metabolic, and functional abnormalities in diabetic ratsCurr Eye Res2009341192893819958109
   PubMed Web of Science ®Google Scholar
• MirandaMMuriachMJohnsenSOxidative stress in a model for experimental diabetic retinopathy: treatment with antioxidantsArch Soc Esp Oftalmol2004796289294 Spanish15221675
   PubMedGoogle Scholar
• KowluruRAKennedyATherapeutic potential of anti-oxidants and diabetic retinopathyExpert Opin Investig Drugs200110916651676
   PubMed Web of Science ®Google Scholar
• MidenaEVujosevicSMicroperimetry in diabetic retinopathySaudi J Ophthalmol201125213113523960914
   PubMedGoogle Scholar
• MalagolaRSpinucciGCofoneCPattavinaLProspective microperimetry and OCT evaluation of efficacy of repeated intravitreal bevacizumab injections for persistent clinically significant diabetic macular edemaInt Ophthalmol201333326126723242589
   PubMed Web of Science ®Google Scholar
• ArterburnLMHallEBOkenHDistribution, interconversion, and dose response of n-3 fatty acids in humansAm J Clin Nutr200683Suppl 61467S1476S16841856
   PubMed Web of Science ®Google Scholar
• BrowningLMWalkerCGManderAPIncorporation of eicosapentaenoic and docosahexaenoic acids into lipid pools when given as supplements providing doses equivalent to typical intakes of oily fishAm J Clin Nutr201296474875822932281
   PubMed Web of Science ®Google Scholar
• Pinazo-DuránMDGalbis-EstradaCPons-VázquezSCantú-DibildoxJMarco-RamírezCBenítez-del-CastilloJEffects of a nutraceutical formulation based on the combination of antioxidants and ω-3 essential fatty acids in the expression of inflammation and immune response mediators in tears from patients with dry eye disordersClin Interv Aging2013813914823430672
   PubMed Web of Science ®Google Scholar
• Galbis-EstradaCPinazo-DuránMDCantú-DibildoxJMarco-RamírezCDíaz-LlópisMBenítez-del-CastilloJPatients undergoing long-term treatment with antihypertensive eye drops responded positively with respect to their ocular surface disorder to oral supplementation with antioxidants and essential fatty acidsClin Interv Aging2013871171923818768
   PubMed Web of Science ®Google Scholar
• RibellesAGalbis-EstradaCParrasMAVivar-LlopisBMarco-RamírezCDiaz-LlopisMOcular surface and tear film changes in older women working with computersBiomed Res Int2015201546703926557673
   PubMed Web of Science ®Google Scholar
• ChristianLMYoungASMitchellAMBody weight affects ω-3 polyunsaturated fatty acid (PUFA) accumulation in youth following supplementation in post-hoc analyses of a randomized controlled trialPLoS One2017124e017308728379964
   PubMed Web of Science ®Google Scholar
• DyerbergJMadsenPMøllerJMAardestrupISchmidtEBBioavail-ability of marine n-3 fatty acid formulationsProstaglandins Leukot Essent Fatty Acids201083313714120638827
   PubMed Web of Science ®Google Scholar
• NeubronnerJSchuchardtJPKresselGMerkelMvon SchackyCHahnAEnhanced increase of omega-3 index in response to long-term n-3 fatty acid supplementation from triacylglycerides versus ethyl estersEur J Clin Nutr201165224725421063431
   PubMed Web of Science ®Google Scholar
• ChenHZhangXLiaoNWenFIncreased levels of IL-6, sIL-6R, and sgp130 in the aqueous humor and serum of patients with diabetic retinopathyMol Vis2016221005101427563232
   PubMed Web of Science ®Google Scholar
• Simó-ServatOSimóRHernándezCCirculating biomarkers of diabetic retinopathy: an overview based on physiopathologyJ Diabetes Res20162016526379827376090
   PubMed Web of Science ®Google Scholar
• ChousAPRicherSPGersonJDKowluruRAThe Diabetes Visual Function Supplement Study (DiVFuSS)Br J Ophthalmol2016100222723426089210
   PubMed Web of Science ®Google Scholar